AVP and atrial fibrillation: Non-responders developed atrial fibrillation within twelve hours after initiation of AVP treatment more frequently than responders (14% vs. 4%, p = 0.013), which was associated with ICU mortality (OR 3.62, 95%CI 1.05–12.49) in logistic regression.